Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine versus fentanyl as adjuvants to lidocaine for axillary plexus block
IRCT20180426039423N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- May 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of dexmedetomidine, fentanyl and lidocaine in pain (2 arms), sponsored by Kurdistan University of Medical Sciences. Primary endpoint: Visual Analogue Scale for pain intensity. Started May 2018; status: completed.
02
Drugs
dexmedetomidinefentanyllidocaine
03
Conditions
pain
Beyond the preview
Go deeper on IRCT20180426039423N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180426039423N1.